BioMarin : BMRN

All BioMarin Articles

169 Articles

Chris Lange | Mar 1, 2021 at 12:01 PM EST

BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon’s Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas,…

Lee Jackson | Dec 16, 2020 at 8:31 AM EST

Goldman Sachs Adds Pharmaceutical Giant to Conviction List of Top Stocks to Buy

In a move that investors looking for more defensive ideas should applaud, the analysts at Goldman Sachs have added Bristol-Myers…

Chris Lange | Oct 17, 2020 at 8:40 AM EDT

7 Large Biotechs Expected to Outperform This Earnings Season

Earnings season is upon us and investors are pining for information about which stocks and sectors will do well. After…

Lee Jackson | Aug 20, 2020 at 9:07 AM EDT

Top Analyst Upgrades and Downgrades: BioMarin, Checkpoint Software, Cinemark, Fortinet, Palo Alto, Regeneron, Shake Shack, Ventas, Zscaler and More

Thursday's top analyst upgrades and downgrades included BioMarin Pharmaceuticals, Checkpoint Software Technologies, Cinemark, Fortinet, Palo Alto Networks, Regeneron Pharmaceuticals, Shake…

Chris Lange | Aug 19, 2020 at 9:55 AM EDT

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

BioMarin Pharmaceutical stock was crushed on Wednesday after an FDA response regarding its valoctocogene roxaparvovec gene therapy for severe hemophilia…

Chris Lange | Jul 24, 2020 at 10:51 AM EDT

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm…

Jon C. Ogg | Jun 10, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Boeing, Chevron, Chewy, Cisco, Cree, eBay, Etsy, GameStop, Groupon, Micron, United Airlines, Yext and More

Wednesday's top analyst upgrades and downgrades Apple, Boeing, Chevron, Chewy, Cisco Systems, Cree, eBay, Etsy, GameStop, Groupon, Micron Technology, United…

Lee Jackson | Jun 10, 2020 at 7:17 AM EDT

Jefferies 5 High-Conviction Health Care Stocks to Buy for the Second Half

These five high-conviction health care picks make sense for accounts looking to gain exposure to a sector that should continue…

Lee Jackson | May 26, 2020 at 7:25 AM EDT

Jefferies Makes Incredibly Large Changes to Its Franchise Picks List

With the potential for continued economic and political volatility, now is probably a good time for a little spring cleaning…

Lee Jackson | May 11, 2020 at 7:24 AM EDT

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

These are five of the best stocks in a sector that has been humming along in what has been a…

Lee Jackson | Apr 27, 2020 at 7:15 AM EDT

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies…

Jon C. Ogg | Mar 24, 2020 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Alcoa, Biomarin, Coca-Cola, Ford, GM, Intel, Kinder Morgan, Micron, Nvidia, Tesla, Twitter, Zillow and More

Tuesday's top analyst calls included Advanced Micro Devices, Alcoa, Biomarin Pharmaceutical, Coca-Cola, Ford, General Motors, Intel, Kinder Morgan, Micron Technology,…

Chris Lange | Jan 19, 2020 at 7:05 AM EST

American Airlines, Netflix, Starbucks and More Major Earnings This Week

24/7 Wall St. has put together a preview of AbbVie, American Airlines, Netflix, Starbucks and some of the other most…

Lee Jackson | Jan 10, 2020 at 7:15 AM EST

5 Goldman Sachs Conviction List Stocks With Massive Upside Potential for 2020

These five top stocks spread across different sectors offer tremendous upside to the Goldman Sachs price objectives.

Jon C. Ogg | Nov 12, 2019 at 9:15 AM EST

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva…

1 2 3 4 5 … 12

BioMarin : BMRN

All BioMarin Articles

BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon’s Analyst Calls

Goldman Sachs Adds Pharmaceutical Giant to Conviction List of Top Stocks to Buy

7 Large Biotechs Expected to Outperform This Earnings Season

Top Analyst Upgrades and Downgrades: BioMarin, Checkpoint Software, Cinemark, Fortinet, Palo Alto, Regeneron, Shake Shack, Ventas, Zscaler and More

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Top Analyst Upgrades and Downgrades: Apple, Boeing, Chevron, Chewy, Cisco, Cree, eBay, Etsy, GameStop, Groupon, Micron, United Airlines, Yext and More

Jefferies 5 High-Conviction Health Care Stocks to Buy for the Second Half

Jefferies Makes Incredibly Large Changes to Its Franchise Picks List

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

Top Analyst Upgrades and Downgrades: AMD, Alcoa, Biomarin, Coca-Cola, Ford, GM, Intel, Kinder Morgan, Micron, Nvidia, Tesla, Twitter, Zillow and More

American Airlines, Netflix, Starbucks and More Major Earnings This Week

5 Goldman Sachs Conviction List Stocks With Massive Upside Potential for 2020

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

BioMarin : BMRN

All BioMarin Articles

BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon’s Analyst Calls

Goldman Sachs Adds Pharmaceutical Giant to Conviction List of Top Stocks to Buy

7 Large Biotechs Expected to Outperform This Earnings Season

Top Analyst Upgrades and Downgrades: BioMarin, Checkpoint Software, Cinemark, Fortinet, Palo Alto, Regeneron, Shake Shack, Ventas, Zscaler and More

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Top Analyst Upgrades and Downgrades: Apple, Boeing, Chevron, Chewy, Cisco, Cree, eBay, Etsy, GameStop, Groupon, Micron, United Airlines, Yext and More

Jefferies 5 High-Conviction Health Care Stocks to Buy for the Second Half

Jefferies Makes Incredibly Large Changes to Its Franchise Picks List

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

Top Analyst Upgrades and Downgrades: AMD, Alcoa, Biomarin, Coca-Cola, Ford, GM, Intel, Kinder Morgan, Micron, Nvidia, Tesla, Twitter, Zillow and More

American Airlines, Netflix, Starbucks and More Major Earnings This Week

5 Goldman Sachs Conviction List Stocks With Massive Upside Potential for 2020

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

XRP Price Prediction: 3 AI Models Predict Where XRP Will Trade by December 2026

QDVO’s 32% Return Masks a Hidden Risk for Income Investors

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

Featured Reads

Half of America Still Feels Financially Exposed Despite 8% Jump in Security

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk